drugset / Trial / NCT00375960
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of this study is to investigate the safety and efficacy of an investigational drug, V3381, for the treatment of diabetic peripheral neuropathic (DPN) pain (pain in one's feet and legs, or even in one's hands and arms, sometimes experienced by people with diabetes). An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA) and/or Health Canada.
Timeline
- Start
- 2006-06
- Primary completion
- —
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indantadol | Unknown | 200 mg | Oral |
| Subject | Indantadol | Unknown | 400 mg | Oral |